-
Je něco špatně v tomto záznamu ?
Physiological effects of different types of beta-glucan
V. Vetvicka, J. Vetvickova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
- MeSH
- beta-glukany farmakologie MeSH
- cholesterol krev MeSH
- fagocytóza účinky léků MeSH
- interleukin-2 biosyntéza MeSH
- krevní glukóza účinky léků MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Numerous types of glucans have been isolated from almost every species of yeast, grain, and fungi. These products have been extensively studied for their immunological and pharmacological effects. AIM: In this paper we evaluated the possibility whether individual glucans will be similarly active against each of the tested biological properties or if each glucan will affect different reactions. METHODS: Immunological effects of glucans were measured by evaluation of phagocytosis of HEMA particles by peripheral blood leukocytes and production of IL-2 by mouse splenocytes. Next we measured the effects of long-term treatment with glucan on levels of blood glucose and blood cholesterol. Four different glucans differing in origin (yeast, grain and mushroom) were used. RESULTS: Our results showed that the same glucan, yeast-derived insoluble #300 glucan, stimulated phagocytosis of peripheral blood leukocytes, production of IL-2 by mouse splenocytes, lowered the cholesterol levels in mice with experimentally-induced cholesterolemia and lowered the level of blood sugar after induced hyperglycaemie. The remainder of tested glucans were only marginally active. CONCLUSION: Taken together, our study showed that with respect to natural glucans, there is a yes-or-no effect suggesting that highly purified and highly active glucans will have pleiotropic impact, whereas poorly isolated and/or less active glucans will have only mediocre biological properties.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003611
- 003
- CZ-PrNML
- 005
- 20130222133515.0
- 007
- ta
- 008
- 130128s2007 xr d f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)18345255
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Větvička, Václav, $d 1954- $7 skuk0001572 $u University of Louisville, Department of Pathology, Louisville, KY, USA
- 245 10
- $a Physiological effects of different types of beta-glucan / $c V. Vetvicka, J. Vetvickova
- 520 9_
- $a BACKGROUND: Numerous types of glucans have been isolated from almost every species of yeast, grain, and fungi. These products have been extensively studied for their immunological and pharmacological effects. AIM: In this paper we evaluated the possibility whether individual glucans will be similarly active against each of the tested biological properties or if each glucan will affect different reactions. METHODS: Immunological effects of glucans were measured by evaluation of phagocytosis of HEMA particles by peripheral blood leukocytes and production of IL-2 by mouse splenocytes. Next we measured the effects of long-term treatment with glucan on levels of blood glucose and blood cholesterol. Four different glucans differing in origin (yeast, grain and mushroom) were used. RESULTS: Our results showed that the same glucan, yeast-derived insoluble #300 glucan, stimulated phagocytosis of peripheral blood leukocytes, production of IL-2 by mouse splenocytes, lowered the cholesterol levels in mice with experimentally-induced cholesterolemia and lowered the level of blood sugar after induced hyperglycaemie. The remainder of tested glucans were only marginally active. CONCLUSION: Taken together, our study showed that with respect to natural glucans, there is a yes-or-no effect suggesting that highly purified and highly active glucans will have pleiotropic impact, whereas poorly isolated and/or less active glucans will have only mediocre biological properties.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krevní glukóza $x účinky léků $7 D001786
- 650 _2
- $a cholesterol $x krev $7 D002784
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a interleukin-2 $x biosyntéza $7 D007376
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a fagocytóza $x účinky léků $7 D010587
- 650 _2
- $a beta-glukany $x farmakologie $7 D047071
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Větvičková, Jana, $d 1966- $7 jn20001103377 $u University of Louisville, Department of Pathology, Louisville, KY, USA
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 151, č. 2 (2007), s. 225-231
- 856 41
- $u http://biomed.papers.upol.cz/magno/bio/2007/mn2.php $y domovská stránka časopisu - plný text volně přístupný = fulltext
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20130222133709 $b ABA008
- 999 __
- $a ok $b bmc $g 966267 $s 801806
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2007 $b 151 $c 2 $d 225-231 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK111 $a Pubmed-20130128